Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals-Reference-Cited by-同舟云学术

Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals

Published:2018-02-05 Issue:3 Volume:21 Page:424-431
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Jacobs Heidi I. L.^ORCID,Hedden Trey,Schultz Aaron P.,Sepulcre Jorge,Perea Rodrigo D.,Amariglio Rebecca E.,Papp Kathryn V.,Rentz Dorene M.,Sperling Reisa A.,Johnson Keith A.

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/s41593-018-0070-z.pdf

Reference71 articles.

1. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).

2. Braak, H. & Braak, E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92, 197–201 (1996).

3. Ahmed, Z. et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127, 667–683 (2014).

4. Khan, U. A. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer’s disease. Nat. Neurosci. 17, 304–311 (2014).

5. Hu, W. et al. Hyperphosphorylation determines both the spread and the morphology of tau pathology. Alzheimers Dement. 12, 1066–1077 (2016).

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connectome-based predictive modeling of brain pathology and cognition in Autosomal Dominant Alzheimer’s Disease;2024-09-03

2. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

3. Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals;Annals of Neurology;2024-07-15

4. Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease;Acta Pharmaceutica Sinica B;2024-07

5. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease;Nature Communications;2024-06-12